Stomach News and Research

RSS

AMDL Diagnostics to focus on in vitro diagnostic cancer tests

AMDL Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major operations in China, announced the inauguration of AMDL Diagnostics Inc. (ADI), a new wholly-owned subsidiary that will focus on the research, development, manufacture and international sales of Onko-Sure(TM)-- AMDL's proprietary, regulatory approved in vitro diagnostic (IVD) cancer test.

21 Aug 2009

Diet pills, alcohol, caffeine, nicotine, amphetamines and cocaine abused by patients with eating disorders

Between 11 and 13 million people in the U.S. have eating disorders and at least one million will die from their disorder. It is not unusual for women and girls struggling with eating disorders to either abuse or become dependent on over-the-counter substances.

20 Aug 2009

Surgeons of BMI of Texas selected to host a preceptorship for using REALIZE Adjustable Gastric Band

The Bariatric Medical Institute of Texas (“BMI of Texas”) today announced surgeons Mickey Seger and Terive Duperier have been selected by Ethicon Endo-Surgery, Inc. as one of the five training sites in the U.S. to host a preceptorship for the Ethicon Endo-Surgery REALIZE™ Adjustable Gastric Band.

20 Aug 2009

SFDA approves China Pharma Holdings' generic Omeprazole Sodium injection

China Pharma Holdings, Inc., which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it has received approval from the Chinese State Food and Drug Administration ("SFDA) for the production of generic Omeprazole Sodium injections.

19 Aug 2009

Infant sleep environments depicted in magazines targeted to women of childbearing age

More than one third of photos in women's magazines depicted babies in unsafe sleep positions, according to a new study in Pediatrics. Additionally, the study found that two-thirds of sleep environments depicted in these magazines were also unsafe.

17 Aug 2009

How to stop osteoarthritis pain

When arthritis affects the hands, a range of treatments may reduce pain and preserve joint mobility. The August issue of Mayo Clinic Health Letter provides an overview.

13 Aug 2009

Clever biochemical strategy enables bacteria to move freely and colonize host

A team of researchers from Boston University, Harvard Medical School and Massachusetts Institute of Technology recently made a discovery that changes a long held paradigm about how bacteria move through soft gels.

13 Aug 2009

Factors associated with use of gastric cancer screening services in Korea

The mortality of gastric cancer is decreasing despite the increasing incidence in Korea. This can be explained by surgical technique development and early detection by endoscopic screening or upper gastrointestinal study.

12 Aug 2009

Scientists take the first step to targeted treatment for stomach cancer

Researchers have identified a protein that plays an important role in the development of stomach cancers and that could one day be a target for new treatments for the disease, according to research published (Wednesday) in the British Journal of Cancer.

12 Aug 2009

H5N1 avian influenza leaves people at increased risk for Parkinson's disease

At least one strain of the H5N1 avian influenza virus leaves survivors at significantly increased risk for Parkinson's disease and possibly other neurological problems later in life, according to new research from St. Jude Children's Research Hospital.

10 Aug 2009

Proteomics helps find key to keeping cells in shape

Yale University researchers have discovered how a protein within most cell membranes helps maintain normal cell size, a breakthrough in basic biology that has implications for a variety of diseases such as sickle cell anemia and disorders of the nervous system.

6 Aug 2009

Stomach cancer cases almost halve over the last 30 years

New Cancer Research UK figures out today reveal that stomach cancer cases in Great Britain have dropped by nearly half from around 14,000 in 1975 to 7,485 in 2006.

6 Aug 2009

Heavy drinkers have much higher risk of developing cancer

Heavy drinkers of beer and spirits face a much higher risk of developing cancer than the population at large, says a group of Montreal epidemiologists and cancer researchers.

4 Aug 2009

Heavy consumption of beer and spirits to 6 different cancers

Heavy drinkers of beer and spirits face a much higher risk of developing cancer than the population at large, says a group of Montreal epidemiologists and cancer researchers. Their findings show that people in the highest consumption category increased their risk of developing oesophageal cancer sevenfold, colon cancer by 80% and even lung cancer by 50%.

3 Aug 2009

New nano-gene therapy technique could fight late-stage tumors

Tiny particles carrying a killer gene can effectively suppress ovarian tumor growth in mice, according to a team of researchers from MIT and the Lankenau Institute.

31 Jul 2009

Short-term complications after bariatric surgery for extreme obesity low

Short-term complications and death rates were low following bariatric surgery to limit the amount of food that can enter the stomach, decrease absorption of food or both, according to the Longitudinal Assessment of Bariatric Surgery (LABS-1). The study was funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health. Results are reported in the July 30 issue of the New England Journal of Medicine.

30 Jul 2009

Deferoxamine could help diabetics heal wounds

A drug used to remove iron from the body could help doctors fight one of diabetes' cruelest complications: poor wound healing, which can lead to amputation of patients' toes, feet and even legs.

28 Jul 2009

Peanut allergies could soon become a thing of the past

Research by a team at Addenbrooke's Hospital in Cambridge brings hope to children suffering nut allergies of leading a normal life following the success of a pioneering experimental therapy which has allowed the immune system to be 'retrained' to tolerate peanuts and patients with food allergies become desensitised to the food.

20 Jul 2009

Largest-ever study looks at safety of Non-Steroidal Anti-Inflammatory drugs (NSAIDS)

They are a group of drugs which millions of people rely on to keep pain at bay but they can have unwanted side-effects which are sometimes more serious than the original health problem. Now scientists at The University of Nottingham are taking part in the largest-ever study on the safety of Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) that has ever been performed.

12 Jul 2009

NDA for Exenatide once weekly accepted for FDA review

Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced that the New Drug Application (NDA) for exenatide once weekly has been accepted for review by the U.S. Food and Drug Administration (FDA).

7 Jul 2009